Have a feature idea you'd love to see implemented?
Let us know!
TMCI Treace Medical Concepts Inc
Price (delayed)
$4.93
Market cap
$306.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.02
Enterprise value
$357.88M
Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The
Highlights
TMCI's revenue is up by 19% YoY
Treace Medical Concepts's gross profit has increased by 18% YoY
Treace Medical Concepts's quick ratio has shrunk by 51% YoY and by 9% QoQ
The company's net income has shrunk by 51% YoY and by 16% QoQ
Key stats
What are the main financial stats of TMCI
Market
Valuations
Earnings
Shares outstanding
62.19M
Market cap
$306.6M
Enterprise value
$357.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.73
Price to sales (P/S)
1.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.8
Revenue
$198.53M
EBIT
-$58.46M
EBITDA
-$48.72M
Free cash flow
-$41.5M
Per share
Balance sheet
Liquidity
EPS
-$1.02
Free cash flow per share
-$0.67
Book value per share
$1.81
Revenue per share
$3.2
TBVPS
$3.3
Total assets
$226.08M
Total liabilities
$113.94M
Debt
$69.46M
Equity
$112.14M
Working capital
$127.11M
Debt to equity
0.62
Current ratio
3.86
Quick ratio
2.71
Net debt/EBITDA
-1.05
Margins
Efficiency
Dividend
EBITDA margin
-24.5%
Gross margin
80.7%
Net margin
-32.1%
Operating margin
-32.7%
Return on assets
-26.5%
Return on equity
-49.5%
Return on invested capital
-25%
Return on capital employed
-32.2%
Return on sales
-29.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TMCI stock price
How has the Treace Medical Concepts stock price performed over time
Intraday
-2.95%
1 week
-6.81%
1 month
-9.21%
1 year
-49.95%
YTD
-61.33%
QTD
-15%
Financial performance
How have Treace Medical Concepts's revenue and profit performed over time
Revenue
$198.53M
Gross profit
$160.16M
Operating income
-$64.95M
Net income
-$63.68M
Gross margin
80.7%
Net margin
-32.1%
The operating income has plunged by 56% YoY and by 15% from the previous quarter
The company's net income has shrunk by 51% YoY and by 16% QoQ
The operating margin is down by 31% YoY and by 13% QoQ
TMCI's net margin is down by 27% YoY and by 15% QoQ
Growth
What is Treace Medical Concepts's growth rate over time
Valuation
What is Treace Medical Concepts stock price valuation
P/E
N/A
P/B
2.73
P/S
1.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.8
The EPS has declined by 42% year-on-year and by 16% since the previous quarter
TMCI's P/B is 49% below its last 4 quarters average of 5.4
The equity has declined by 25% year-on-year and by 11% since the previous quarter
The P/S is 58% below the last 4 quarters average of 3.7
TMCI's revenue is up by 19% YoY
Efficiency
How efficient is Treace Medical Concepts business performance
Treace Medical Concepts's return on invested capital has decreased by 37% YoY and by 23% QoQ
The return on sales has declined by 32% year-on-year and by 16% since the previous quarter
Treace Medical Concepts's ROA has decreased by 27% YoY and by 19% from the previous quarter
The return on equity has declined by 26% year-on-year and by 25% since the previous quarter
Dividends
What is TMCI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TMCI.
Financial health
How did Treace Medical Concepts financials performed over time
TMCI's total assets is 98% greater than its total liabilities
Treace Medical Concepts's quick ratio has shrunk by 51% YoY and by 9% QoQ
Treace Medical Concepts's current ratio has decreased by 42% YoY and by 3% from the previous quarter
TMCI's debt is 38% lower than its equity
The debt to equity has grown by 35% YoY and by 13% from the previous quarter
The equity has declined by 25% year-on-year and by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.